Senior Researcher, Proton Therapy Department; A. Tsyb Medical Radiological Research Centre - Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4 Koroleva St., Kaluga Region, Obninsk, 249036, Russia.
Junior Researcher, Proton Therapy Department; A. Tsyb Medical Radiological Research Centre - Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4 Koroleva St., Kaluga Region, Obninsk, 249036, Russia.
Sovrem Tekhnologii Med. 2021;13(4):70-80. doi: 10.17691/stm2021.13.4.08. Epub 2021 Aug 28.
Proton therapy (PT) due to dosimetric characteristics (Bragg peak formation, sharp dose slowdown) is currently one of the most high-tech techniques of radiation therapy exceeding the standards of photon methods. In recent decades, PT has traditionally been used, primarily, for head and neck cancers (HNC) including skull base tumors. Regardless of the fact that recently PT application area has significantly expanded, HNC still remain a leading indication for proton radiation since PT's physic-dosimetric and radiobiological advantages enable to achieve the best treatment results in these tumors. The present review is devoted to PT usage in HNC treatment in the world and Russian medicine, the prospects for further technique development, the assessment of PT's radiobiological features, a physical and dosimetric comparison of protons photons distribution. The paper shows PT's capabilities in the treatment of skull base tumors, HNC (nasal cavity, paranasal sinuses, nasopharynx, oropharynx, and laryngopharynx, etc.), eye tumors, sialomas. The authors analyze the studies on repeated radiation and provide recent experimental data on favorable profile of proton radiation compared to the conventional radiation therapy. The review enables to conclude that currently PT is a dynamic radiation technique opening up new opportunities for improving therapy of oncology patients, especially those with HNC.
质子治疗(PT)由于剂量学特性(布拉格峰形成,剂量急剧下降),是目前超过光子方法标准的最先进的放射治疗技术之一。近几十年来,PT 主要用于头颈部癌症(HNC),包括颅底肿瘤。尽管最近 PT 的应用领域已经大大扩大,但 HNC 仍然是质子放射治疗的主要适应症,因为 PT 的物理剂量学和放射生物学优势使这些肿瘤能够达到最佳的治疗效果。本文综述了世界和俄罗斯医学中 PT 在 HNC 治疗中的应用,进一步发展该技术的前景,PT 放射生物学特性的评估,质子和光子分布的物理和剂量学比较。本文展示了 PT 在颅底肿瘤、HNC(鼻腔、鼻窦、鼻咽、口咽和喉咽等)、眼部肿瘤、唾液腺肿瘤治疗中的作用。作者分析了重复放射治疗的研究,并提供了质子放射治疗与传统放射治疗相比具有良好优势的最新实验数据。综述结果表明,目前 PT 是一种具有活力的放射治疗技术,为改善肿瘤患者,特别是 HNC 患者的治疗提供了新的机会。